Simplex Trading’s SQZ Biotechnologies Company SQZ Stock Holding History

Simplex Trading’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,600	Closed	-$7K	–	11508
2022 Q1	$7K	Buy	+1,600	New	+$10.2K	﹤0.01%	9238

Other funds holding SQZ

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Simplex Trading's SQZ Position: Q4 2022 in Review

Simplex Trading sold out of SQZ Biotechnologies Company (SQZ) in Q4 2022, closing a stake of 403 shares.

Simplex Trading first reported a position in SQZ in Q4 2021 and held it in 4 quarters. The position peaked at $6K in Q1 2022. 36 funds tracked by Wall St. Rank hold SQZ as of Q4 2022.

Simplex Trading reported no remaining SQZ Biotechnologies Company position as of Q4 2022 after selling out during the quarter.
Simplex Trading sold 403 SQZ Biotechnologies Company shares in Q4 2022.
Simplex Trading first reported a position in SQZ Biotechnologies Company in Q4 2021 and held it in 4 quarters.
Simplex Trading's SQZ Biotechnologies Company position peaked at $6K in Q1 2022.
36 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.